Top News

GPhA Rebrands Itself and Changes its Name to the Association for Accessible MedicinesGPhA, the generic drug industry’s leading trade organization, adopted a new name: the Association for Accessible Medicines (AAM). The new name reflects the organization's mission “to make more medicines more accessible to more people who need them.”
Compounding services can help your pharmacy stand outDennis Song, RPh, describes the steps to take when starting a compounding services business.
Why pharmacists are concerned about the safety of biosimilarsPharmacists and other healthcare professionals are looking to the FDA for more guidance on biosimilars and interchangeability with their reference products.
Regs, robbery responses among top “pharmacy gamechangers” for 2016
Regs, robbery responses among top “pharmacy gamechangers” for 2016The issues of most concern to pharmacists, outlined at McKesson’s ideaShare 2016.
The red pen rules: How to prevent pharmacy errorAnxious new pharmacists get a shot in the arm from columnist Pete Kreckel, RPh.
Drug take-back: A call for a permanent solutionA coordinated effort needs to be made to preserve the health and safety of life on earth.
Inside the U.S., European markets for biosimilarsDespite barriers to their adoption in the U.S. and Europe, biosimilars have produced healthcare savings in Europe. Similar savings are projected for the U.S. market.
Biosimilars for cancer treatment on the U.S. horizonCancer treatments are expected to dominate much of the first wave of biosimilars in the U.S. This Q&A discussion looks at some of the questions pharmacists have about use of biosimilars in cancer treatment.
Easing the bite from generic drug price increasesGeneric drug price hikes are not likely to disappear anytime soon. Find out why they're occurring and what can be done about them.
Every pharmacist has them — and so does every teacherWhat do pharmacists and teachers — and an awful lot of other people — have in common?